Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbitrap mass spectrometry coupled with principal component analysis

[Display omitted] •The report describes the validation with high precision and accuracy of an UHPLC-Q-orbitrap MS method for the determination of 30 bioactive constituents in XueBiJing injection for the first time.•The high resolution hybrid quadrupole-orbitrap mass spectrometry possess high accurac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2017-04, Vol.137, p.220-228
Hauptverfasser: Zuo, Lihua, Sun, Zhi, Hu, Yurong, Sun, Ya, Xue, Wenhua, Zhou, Lin, Zhang, Jun, Bao, Xiaoyue, Zhu, Zhenfeng, Suo, Guanglu, Zhang, Xiaojian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •The report describes the validation with high precision and accuracy of an UHPLC-Q-orbitrap MS method for the determination of 30 bioactive constituents in XueBiJing injection for the first time.•The high resolution hybrid quadrupole-orbitrap mass spectrometry possess high accuracy and stability, and so the full MS scan mode with positive/negative ion swing was performed.•This method was simple and time saving.•The determination results were analyzed by multivariate analysis in order to discover the markers for quality control of XBJ injection. Xuebijing injection (XBJ) is a traditional Chinese herbal prescription widely used in the treatment of sepsis. Extensive chemical studies revealed that XBJ injection contains amino acids, phenolic acids, flavonoid glycosides, terpeneglycosides and phthalides. In this study, the applicability of ultra high performance liquid chromatography coupled with high resolution hybrid quadruple-orbitrap mass spectrometry (UHPLC-Q-Orbitrap MS) for the simultaneous quantitative analysis of 30 bioactive constituents in XueBiJing injection (XBJ) was investigated. The mass spectrometer was operated in full MS scan mode. The use of 70,000FWHM mass resolution and narrow mass windows (5ppm) could effectively improve the selectivity of the method. Separation was achieved on a Waters ACQUITY UPLC® HSS C18 column (2.1mm×100mm, 1.8μm) with a gradient mobile phase consisting of acetonitrile-water (containing 10mM ammonium acetate) at a flow rate of 0.2mL/min. Satisfactory linearity was achieved within wide linear range and all correlation coefficients (r) of analytes were more than 0.9996. The limits of detection (LODs) were in the range of 0.1180–27.82ng/mL for different analytes. The relative standard deviations (RSDs) of inter- and intra-day precisions were less than 3.0% and the recoveries of the assay were in the range of 98.5%–101.5%. The validated method was successfully applied for simultaneous determination of 30 bioactive compounds in XueBiJing injection from 10 batches samples by UHPLC-Q-Orbitrap MS within 10min. Moreover, the results were evaluated principal component analysis and two compounds might be the most important chemical markers for chemical quality control of XBJ injection. The novel Q-Orbitrap mass spectrometry has been proved to be a very promising and powerful tool for routine screening of bioactive compounds in traditional Chinese medicine injection, ensuring drug safety and public health.
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2017.01.024